drugset / Trial / NCT00873015
Safety and Pharmacokinetic Evaluation of Nitrite for Prevention of Cerebral Vasospasm
Phase 2
Completed
19 enrolled
Hope Pharmaceuticals
National Institute of Neurological Disorders and Stroke (NINDS) · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of the study is to examine the safety of a 14 day infusion of sodium nitrite, and to study the pharmacokinetics of nitrite, during a 14 day infusion in patients with ruptured cerebral aneurysms.
Timeline
- Start
- 2010-04
- Primary completion
- 2010-11
- Completion
- 2012-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sodium Nitrite | Small molecule | 32 unknown | Intravenous |
| Subject | Sodium Nitrite | Small molecule | 48 unknown | Intravenous |
| Subject | Sodium Nitrite | Small molecule | 64 unknown | Intravenous |